How to Become a Clinical Trial Site: A Guide for Independent Practices

Most independent practices could be running clinical trials and getting paid for it. Very few do. It usually isn't because they can't qualify. It's that the whole thing looks like a bureaucratic maze from the outside, so nobody starts.

It's more approachable than it looks, and the timing is good. Recruitment is the number-one reason trials fall behind or get scrapped, and a small group of sites does most of the enrolling, so sponsors are hunting for new practices that can actually deliver patients. If you see a steady stream of people with common conditions, they probably want you.

Here's what it takes to become a site: who does what, the steps in order, the paperwork, how the money works, how long it takes, and the part nobody warns you about, which is getting sponsors to notice you in the first place.

You don't need a research background or a research department to start. Almost everyone running their first trial is, by definition, doing it for the first time.

What a clinical trial site is

A site is where the patients are. Usually that's a physician's practice that agrees to enroll and manage participants in a study for a sponsor (a drug or device company) or the CRO the sponsor hires to run it. You recruit eligible patients, walk them through informed consent, do the visits and procedures the protocol spells out, and record the data cleanly. The sponsor pays you for that work.

You're not designing the study or inventing the drug. You're running someone else's protocol with real patients. If you already treat type 2 diabetes, obesity, high cholesterol, or heart disease, a lot of it looks like the medicine you practice every day.

Can your practice qualify?

Probably, as long as you see enough patients in an area sponsors are studying and you're willing to build a little process around it.

A few things worth clearing up:

• Small and independent is fine. Sponsors want community practices now, not just academic centers. Roughly 70% of Americans live more than two hours from a major academic medical center, so trials have to come to where people actually get their care.
• No prior research experience needed. Plenty of investigators start cold. A common first move is to take an easier study (a later-phase or vaccine trial) to build a track record.
• Your patient mix is the real qualifier. What you treat decides which studies you can fill.

The people: who does what

Three roles do most of the work.

The Principal Investigator (PI) is the physician on the hook for the trial at your site. The guidelines only say they have to be "appropriately qualified by education, training, and experience," which in practice means a licensed MD or DO in a relevant specialty. You don't need research on your CV to start, but you do need Good Clinical Practice (GCP) training.

Sub-investigators are other clinicians, often physicians or NPs and PAs, who handle trial tasks under the PI. They go on the regulatory paperwork and need GCP training too.

The Clinical Research Coordinator (CRC) is the person who really runs the day-to-day: booking visits, screening and consenting patients, keeping the protocol straight, writing everything down, entering the data, and tracking the study drug. A lot of practices train up a nurse or medical assistant they already have. Others hire someone certified through ACRP or SOCRA.

If you want the deeper version, the open-access primer for aspiring principal investigators is worth a read. If you're weighing the investigator role yourself, see how to become a Principal Investigator.

How to become a clinical trial site, step by step

None of these steps is hard on its own. In roughly this order:

1. Pick your focus and your role. Which conditions match your patients, and will your physician be the PI, a sub-investigator, or both.
2. Set up basic infrastructure and a site profile. Secure, temperature-monitored drug storage, a private room for visits, a way to keep source documents, and a handful of standard operating procedures. Then write up a site profile covering patient volume, staff, equipment, and any past experience. Sponsors read this to size you up.
3. Get on sponsors' and CROs' radar. This is the hard one, and it gets its own section below.
4. Fill out feasibility questionnaires. For a specific study, the sponsor sends a form asking about your patients, competing trials, staff, and equipment. Treat it as your application to run that study.
5. Pass a site qualification visit. A monitor (a CRA) comes by, tours the place, and talks to your team to confirm you're ready.
6. Sign a CDA, then work out the budget and contract. The confidentiality agreement usually comes first, before you even see the full protocol. The Clinical Trial Agreement and budget follow.
7. Get IRB approval. An Institutional Review Board signs off on the protocol, the consent form, and anything you'll use to recruit patients.
8. Pull together your regulatory documents (next section).
9. Do the site initiation visit. The CRA trains your team on the specific protocol and switches you on.
10. Start enrolling. First patient in.

The paperwork you'll need

New sites need roughly the same stack every time:

• Form FDA 1572, the Statement of Investigator, required for drug and biologic trials run under an IND. It's the PI's signature promising to follow the protocol, GCP, and FDA rules, and it names the investigators, the facilities, and the IRB. Device trials skip it and use an Investigator Agreement instead. The FDA's 1572 FAQ is the plain-English version.
• Financial disclosure forms (FDA 3455 and 3454) covering any financial ties to the sponsor.
• GCP / ICH E6 training certificates for the PI and staff, kept current.
• Current CVs and medical licenses for the PI and sub-investigators.
• CLIA lab certification and normal reference ranges for whatever lab runs your study tests.
• A delegation of authority log that says who's allowed to do what, signed by the PI.
• Your IRB approval letter.

None of it is difficult. It just has to be complete and current. Half-finished binders and delegation logs are one of the most common things that trip up a new site.

How the money works

The sponsor or CRO pays you under the budget you negotiate, and it comes in a few pieces:

• Per-patient payments are the main event. A set amount for each participant who completes the visits, or the whole study, usually paid quarterly or at milestones. The range is huge. A simple later-phase study might pay a few thousand dollars a patient; a complex one can pay much more. Ignore the eye-popping "$50,000 a patient" numbers floating around online, which are cherry-picked. What you make depends on the protocol.
• Per-visit and per-procedure reimbursement, built from staff time and each test the protocol requires.
• A start-up fee, usually a few thousand dollars, for the upfront setup and contracting.
• Screen-failure payments that cover part of your cost when a patient you screen doesn't qualify.
• A holdback: a slice of the money, often around 10% and sometimes 15 to 20%, that the sponsor keeps until the study closes and the data is clean.

Two things to plan around. The money shows up after the work, on net-30 to net-90 terms, and late payment is a common complaint, so don't count on it for expenses you have next month. For a shorter take on the earnings side, see how much clinical trial sites get paid.

How long it takes

If you're already set up and a study is waiting, selection to first patient can be a couple of months. Starting from scratch, plan for several months up to about a year before you enroll anyone. Most of that time isn't paperwork. It's getting picked for a study, contracting, and IRB. Start-up is the slow part of clinical research everywhere, not just for new sites.

The part nobody warns you about

Everything above is learnable. You do it once and it becomes routine. The thing that actually stops independent sites isn't the regulatory side. It's getting found. There's a whole playbook for that in how research sites find and win studies.

Sponsors hand out most studies through existing relationships and a short list of sites they already know. Meanwhile about 80% of trials run late or fold because they can't recruit, a big share of sites under-enroll, and most of the enrolling is done by a small minority of high performers. So sponsors constantly need new, capable sites, and they are not good at finding them. That is the whole reason site networks and SMOs exist: they get independent practices in front of sponsors they would never reach alone.

That is the gap TrialWave closes. It's business-development software for sites. It finds the studies that fit your patients, scores them, runs the outreach to the sponsors and CROs behind them, and keeps your pipeline, feasibility forms, agreements, and documents in one place. It doesn't run the trial or give you medical or regulatory advice. It gets you in the room.

Mistakes that sink new sites

• Underestimating the money and the wait. A basic setup runs somewhere around $12,000 to $35,000, and the revenue lands later. Holdbacks and slow terms are hard on a small practice.
• Taking a first study your patients don't fit, then failing to enroll.
• Letting the documentation slip. Incomplete binders, delegation logs, sloppy source records.
• Getting qualified and then sitting idle because nobody was working on bringing studies in the door.

Where to start

It's doable. Pick a focus that matches your patients, put a little research process in place, write a strong site profile, get GCP-trained, and then spend real effort getting in front of the sponsors running studies you could fill.

Want to see what's actually recruiting patients like yours right now? Start a free TrialWave trial, no card required, or poke around the demo first.

---

This is general information, not medical, legal, or regulatory advice. Requirements change by study and sponsor, so confirm the current FDA and IRB rules for your own situation.